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Conclusions: Usually radiotherapy provides excellent local and regional control of 
plasmacytomas, but in our case it had no positive effect. The patient is having an evolution which leads 
to an continue worsening without obtaining remission, therefore the long-term prognosis is reserved 
while the medium one is favorable.
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Introduction: In pediatric practice topiramate is used alone or with other medicines to treat 
certain types of seizures and to prevent migraine headaches in adolescents 12 years and older. 
Clinical case: A14 years-old female was admitted into the ER Unit after voluntary ingestion of 
30 capsules (3000 mg) of topiramate. The drug was prescribed by her neurologist for migraines; the 
suicidal attempt was determined by a conflict with her mother. At admission she had dizziness, 
drowsiness, speech disturbances,abnormal coordination, vomiting and abdominal pain. Laboratory data 
showed severe anemia (Hb=4,3 g/dl), normochrome and normocytic, severe metabolic acidosis(HCO3 
- = 6,6 mEq/L), hypoglycemia (37 mg/dl), hypercloremia(Cl-=121,7 mEq/L), hypernatremia (Na+= 150 
mEq/L),hypokalemia (K+ =1,71 mEq/L). The treatment included gastric lavage, activated charcoal, 
intravenous fluids, bicarbonate and blood transfusions. The clinical status improved within 24 hours, Hb 
level raise to 13,8 g/dl and no other laboratory abnormalities were found. The medical records of the 
patient showed she has no anemia previously. A CT scan performed in order to exclude an organic cause 
for her headaches was normal. The patient was dismissed after 10 days in good general condition; she 
presented mild epigastric pain and leave the hospital with proton-pump inhibitor and pshychologic 
counceling recommendations. Subsequently she had several hospitalisations for depression and 
suicidary thoughts treated with sertraline and she is followed by a pediatric psychiatrist.
Conclusions: This is a particular case of voluntary topiramate intoxication with particular side 
effects as severe anemia and metabolic disturbances, followed by long-term behavioral consequences. 
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Introduction: Graves’ ophthalmopathy (GO) is an autoimmune inflammatory disorder 
Associated with thyroid disease which affects ocular and orbital tissues.
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The objective was to present a clinical case of patient with Graves’ disease and GO.
Clinical case: Patient V.P. (45 years) was hospitalize in the Department of Endocrinology on the 
16.03.16, with clinical manifestations: painful feeling behind the globe, redness of the conjunctiva, 
hyperlacrimation, exophthalmos and diplopia. In July 2014, patient was diagnosed with Graves’ disease, 
treatment with ATS was initiated. In April 2015, supports a viral infection that leads to worsening 
general appearance of exophthalmos, decreased eyes motility, sensation of "sand" in the eyes, 
hyperlacrimation and decreased visual acuity. Patient diagnosed with GO and oral Prednisone was given 
in decreasing doses: 30 mg for the first week, after the dose was tapered off by 5 mg per week and GO 
ameliorates. In September 2015, after a virosis, clinical signs of GO becomes more severe and the patient 
resumes treatment with Prednisone. As a result of recently appeared flu (2-3 weeks), GO worsens and 
patient is hospitalized for pulse therapy. Clinical activity score was appreciated according to CAS=6.
Family history: patient’s sister and brother have Graves disease with severe GO. Hormonal tests: 05.15 
FT4-16,8 pmol/L (normal values range = 12-22 pmol/L); 07.15 FT4-33,2 pmol/L; TSH <0,005 mIU/L 
(normal values range 0,27- 4,2 mIU/L); 09.15 FT4-10,8 pmol/L; TSH 0,011 mIU/L; 11.15 FT4-12
pmol/L; TSH 0,185 mIU/L; 01.16 FT4-58,5 pmol/L; TSH <0,005 mIU/L; 03.16 TSH 0,011 mIU/L; FT4 
11,24 pmol/L; FT3 4,32 pmol/L (normal values range 3,1-6,8). MRI of the orbit: diffuse thickening of: 
m.rectus inferior to 1,0 cm (normal values range 0,49-0,57 cm), m. rectus medial to 0,85 cm (normal 
values range 0,41-0,46 cm), m. rectus laterale to 0,7 cm (normal values range 0,29-0,35 cm), m. rectus 
superior to 0,75 cm (normal values range 0,38-0,45 cm) with signs of edema.
The CAS wasn’t determinate before and after Prednisone treatment and we can’t appreciate the 
success of suppressive treatment. In etiology an important role has genetic predisposition (20-60% of 
affected individuals have a positive family history of thyroid disease), 21 % of the risk for developing 
GD is attributable to environmental factors (infectious agents). To confirm the genetic predisposition it 
would be ideal to identify the cytokines: HLA-DR3, CTLA4, PTPN22, CD40, IL-2RA, FCRL3, and IL-
23R. Also, we can’t ignore the influence of other factors in the pathogenesis of GO, such as female 
gender and the age 45 years.
Conclusion:
1. It is important to appreciate the clinical activity score of Graves' ophthalmopathy before and 
after the suppressive treatment.
2. Environmental factors, like viral infections had an important role in the evolution and severity 
of Graves' ophthalmopathy.
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